VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $167.43)
- $167.43 P/E (TTM): 21.97X Cap: $366M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $143.41)
- $143.41 P/E (TTM): 18.7X Cap: $5.74B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $26.56)
- $26.56 Cap: $9.82B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $167.43)
- $167.43 P/E (TTM): 21.97X Cap: $366M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $143.41)
- $143.41 P/E (TTM): 18.7X Cap: $5.74B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $62.10)
- $62.10 Cap: $5.66B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $167.43)
- $167.43 P/E (TTM): 21.97X Cap: $366M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $595.68)
- $595.68 P/E (TTM): 14.9X Cap: $62.74B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $174.21)
- $174.21 P/E (TTM): 18.84X Cap: $424.32B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $754.95)
- $754.95 P/E (TTM): 49.15X Cap: $711.72B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $80.40)
- $80.40 P/E (TTM): 12.57X Cap: $203.59B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.04)
- $24.04 P/E (TTM): 12.78X Cap: $136.68B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $474.99)
- $474.99 P/E (TTM): 27.74X Cap: $179.36B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $60.71)
- $60.71 P/E (TTM): 17.26X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $143.41)
- $143.41 P/E (TTM): 18.7X Cap: $5.74B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $26.56)
- $26.56 Cap: $9.82B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $167.43)
- $167.43 P/E (TTM): 21.97X Cap: $366M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $70.28)
- $70.28 P/E (TTM): 19.22X Cap: $574M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023